Concepedia

Z. Jiang

ZJ

4

Publications

159

Citations

4

H-Index

2009

Active since

Affiliations

Chinese PLA General Hospital(Current)

Second Affiliated Hospital of Dalian Medical University

Fudan University Shanghai Cancer Center

Zhengzhou University

Instituto do Câncer do Estado de São Paulo

Z. Jiang is an author at Chinese PLA General Hospital specializing in breast cancer, cancer therapeutics, and radiation oncology.

Top concepts

Publications per year

2009–2021

4

Publications

4

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study

Qing Yuan Zhang, Tao Sun, Yong Yin et al. · Therapeutic Advances in Medical Oncology · 2020 · 102 citations · Full text

328TiP Phase III study of trastuzumab deruxtecan (T-DXd) with or without pertuzumab vs a taxane, trastuzumab and pertuzumab in first-line (1L), human epidermal growth factor receptor 2–positive (HER2+) metastatic breast cancer (mBC): DESTINY-Breast09

Sara M. Tolaney, Romualdo Barroso‐Sousa, Z. Jiang et al. · Annals of Oncology · 2021 · 26 citations

, , +12

Safety and Efficacy of Neratinib (HKI-272) in Combination with Paclitaxel in ErbB2+ Metastatic Breast Cancer.

Louis W.C. Chow, Sudeep Gupta, Dawn L. Hershman et al. · Cancer Research · 2009 · 16 citations

, , +11

MONARCHplus: A phase III trial of abemaciclib plus nonsteroidal aromatase inhibitor (NSAI) or fulvestrant (F) for women with HR+/HER2- advanced breast cancer (ABC)

Z. Jiang, Xiaolin Hu, Q. Zhang et al. · Annals of Oncology · 2019 · 15 citations

, , +11

Rows per page

1–4 of 4